Puma Biotechnology Inc. (PBYI) Business Metric Overview - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Puma Biotechnology Inc.

    NASDAQ: PBYI · Real-Time Price · USD
    4.70
    -0.02 (-0.42%)
    At close: Sep 25, 2025, 3:59 PM
    4.60
    -2.13%
    After-hours: Sep 25, 2025, 06:59 PM EDT

    Puma Biotechnology Revenue Breakdown

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018
    Product Revenue 49.19M 43.1M 94.66M 56.14M 44.4M 40.28M 53.17M 51.59M 51.55M 46.79M 53.7M 54.29M 51.31M 40.72M 140.21M 43.43M 48.86M 2.35M 50.02M 1.42M 48.77M 48.61M 58.71M 53.48M 53.86M 45.57M 61.08M 52.63M 50.77M
    Product Revenue Growth +14.11% -54.46% +68.62% +26.45% +10.22% -24.24% +3.06% +0.08% +10.17% -12.87% -1.07% +5.79% +26.02% -70.96% +222.87% -11.11% +1976.33% -95.30% +3419.70% -97.09% +0.33% -17.20% +9.77% -0.71% +18.21% -25.40% +16.06% +3.67% n/a
    Royalty Revenue 3.25M 2.9M 8.19M 24.41M 2.69M 3.49M 19.01M 4.52M 3.02M 5.98M 11.97M 2.81M 8.2M 5.02M 5.71M 2.82M 4.28M n/a 2.54M n/a 1.11M 608K 216K 120K 55K n/a n/a n/a n/a
    Royalty Revenue Growth +11.88% -64.55% -66.45% +807.96% -22.91% -81.66% +320.16% +49.95% -49.56% -50.04% +325.26% -65.69% +63.49% -12.12% +102.55% -34.10% n/a n/a n/a n/a +82.73% +181.48% +80.00% +118.18% n/a n/a n/a n/a n/a

    Operating Expense Breakdown

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
    Selling, General, and Administrative Revenue 18.05M 17.6M 17.02M 16.87M 24.97M 21.75M 20.18M 22.18M 24.46M 22.49M 25.1M 23.96M 20.58M 20.4M 22.5M 26.08M 39.41M 28.24M 28.8M 29.6M 29.35M 30.94M 31.3M 31.4M 33.53M 45.5M 41M 28.5M 40.13M 36.6M 30.9M 32.49M 24.93M 18.4M 16.5M 14.02M 12.27M 11.04M 9.6M 8.81M 5.53M 7.87M
    Selling, General, and Administrative Revenue Growth +2.52% +3.43% +0.91% -32.46% +14.81% +7.76% -8.98% -9.35% +8.79% -10.41% +4.75% +16.45% +0.85% -9.32% -13.74% -33.81% +39.56% -1.95% -2.70% +0.86% -5.14% -1.16% -0.32% -6.34% -26.31% +10.98% +43.86% -28.99% +9.65% +18.45% -4.89% +30.33% +35.48% +11.52% +17.67% +14.33% +11.11% +14.99% +8.98% +59.24% -29.72% n/a
    Research and Development Revenue 15.45M 13.86M 15.17M 12.55M 13.63M 13.59M 12.87M 11.45M 13.36M 12.71M 13.8M 11.25M 11.97M 15.24M 14.2M 18.84M 18.64M 20.23M 24.2M 23.34M 24.69M 25.45M 30.2M 30M 36.85M 35.7M 38.4M 36.4M 43.24M 46.92M 50.2M 49.5M 53.25M 54.8M 56.4M 51.98M 54.22M 60.21M 52.5M 51.92M 59.38M 44.73M
    Research and Development Revenue Growth +11.46% -8.61% +20.90% -7.96% +0.33% +5.55% +12.47% -14.31% +5.12% -7.93% +22.63% -5.96% -21.47% +7.30% -24.61% +1.06% -7.86% -16.41% +3.67% -5.46% -3.00% -15.71% +0.67% -18.60% +3.24% -7.03% +5.49% -15.83% -7.84% -6.52% +1.41% -7.04% -2.82% -2.84% +8.51% -4.13% -9.95% +14.68% +1.11% -12.56% +32.76% n/a

    Add to Watchlist